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The efficacy of ACT for treating malaria patients infected
with Plasmodium falciparum may be threatened by para-
sites with reduced responsiveness to artemisinins. Among
298 ACT-treated children from Mbita, Kenya, sub-micro-
scopic persistence of P. falciparum on day 3 post-treat-
ment was associated with subsequent microscopically
detected parasitaemia at days 28 or 42.
Parasite density post-treatment was measured by duplex
probe qPCR at days 1, 2 and 3. DNA sequences of resis-
tance-associated parasite loci pfcrt, pfmdr1, pfubp1 and
pfap2mu were determined in the Mbita cohort before
treatment, on days 2 and 3 after initiation of treatment
and on the day of treatment failure.
Among 298 ACT-treated children from Mbita, Kenya,
sub-microscopic persistence of P. falciparum on day 3
post-treatment was associated with subsequent microsco-
pically detected parasitaemia at days 28 or 42. Parasites
surviving ACT on day 2 or day 3 post-treatment were sig-
nificantly more likely than the baseline population to carry
the wildtype haplotypes of pfcrt (CVMNK at codons 72-
76; P < 0.001) and pfmdr1 (NFD at codons 86, 184, 1246;
P < 0.001). In contrast, variant alleles of the novel candi-
date resistance genes pfap2mu (S160N/T; P = 0.006) and
pfubp-1 (E1528D; P < 0.001) were significantly more pre-
valent post-treatment. No genetic similarities were found
to parasites with reduced sensitivity to short-course arte-
misinin monotherapy, recently described in Cambodia.
We conclude that, among treated children in western
Kenya, certain multi-locus P. falciparum genotypes are
more likely to survive ACT at sub-microscopic level, and
contribute to onward transmission and subsequent patent
recrudescence. These surviving parasites may have an
important public health impact that has been overlooked.
The possible role of both innate and acquired immune
mechanisms in this phenomenon will be discussed.
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